Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics

被引：0
|
作者：
Karagianis, JL [1 ]
Dunayevich, E
机构：
[1] Eli Lilly Canada Inc, Scarborough, ON, Canada
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2005年 / 66卷 / 01期
关键词：
D O I：
10.4088/JCP.v66n0118f
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [31] Fatalities Associated with Therapeutic Use and Overdose of Atypical Antipsychotics
    Adam J. Trenton
    Glenn W. Currier
    Frank L. Zwemer
    [J]. CNS Drugs, 2003, 17 : 307 - 324
  • [32] Are atypical antipsychotics associated with an increased risk of diabetes, and is this associated with weight gain?
    Chue, PS
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2001, 26 (04): : 360 - 360
  • [33] Evaluating Metabolic Syndrome Risk Factors in Patients Receiving Atypical Antipsychotics
    Gradek, Jaroslaw
    [J]. JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2013, 19 (01) : 34 - 35
  • [34] Risk of diabetes, hyperlipidemia, and hypertension and the use of atypical antipsychotics in schizophrenia
    Damler, RM
    Zhao, Z
    Jackson, EA
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S425 - S425
  • [35] Risk of diabetes, hyperlipidemia, and hypertension and the use of atypical antipsychotics in schizophrenia
    Damler, RM
    Zhao, ZY
    Jackson, EA
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S235 - S235
  • [36] RISK OF HOSPITALIZATION FOR PNEUMONIA ASSOCIATED WITH THE USE OF ATYPICAL VERSUS TYPICAL ANTIPSYCHOTICS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES
    Dharmarajan, S. H.
    Yang, Y.
    Athavale, A. S.
    Bentley, J. P.
    Null, K. D.
    Banahan, B. F.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A185 - A185
  • [37] Metabolic risk of atypical antipsychotics: Individualising treatment to improve mental and physical wellness
    Correll, C. U.
    Hanssens, L.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S155 - S155
  • [38] Adverse metabolic effects associated with atypical antipsychotics - Literature review and clinical implications
    Melkersson, K
    Dahl, ML
    [J]. DRUGS, 2004, 64 (07) : 701 - 723
  • [39] Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics
    Yunusa, Ismaeel
    Teng, Chengwen
    Karaye, Ibraheem M.
    Crounse, Emily
    Alsahali, Saud
    Maleki, Nasim
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 13
  • [40] Use of atypical antipsychotics and risk of hypertension: A case report and review literature
    Alves, Beatriz Beretta
    Oliveira, Giovana de Padua
    Moreira Neto, Milton Gabriel
    Fiorilli, Roberta Bonamim
    Santo Cestario, Elizabeth do Espirito
    [J]. SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
12345